Multiple house occupancy is associated with mortality in hospitalized patients with COVID-19.
Journal
European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966
Informations de publication
Date de publication:
01 02 2022
01 02 2022
Historique:
pubmed:
18
5
2021
medline:
5
2
2022
entrez:
17
5
2021
Statut:
ppublish
Résumé
In response to the COVID-19 pandemic, many countries mandated staying at home to reduce transmission. This study examined the association between living arrangements (house occupancy numbers) and outcomes in COVID-19. Study population was drawn from the COPE study, a multicentre cohort study. House occupancy was defined as: living alone; living with one other person; living with multiple other people; or living in a nursing/residential home. Outcomes were time from admission to mortality and discharge (Cox regression), and Day 28 mortality (logistic regression) analyses were adjusted for key comorbidities and covariates including admission: age, sex, smoking, heart failure, admission C-reactive protein (CRP), chronic obstructive pulmonary disease, estimated glomerular filtration rate, frailty and others. A total of 1584 patients were included from 13 hospitals across UK and Italy: 676 (42.7%) were female, 907 (57.3%) were male, median age was 74 years (range: 19-101). At 28 days, 502 (31.7%) had died. Median admission CRP was 67, 82, 79.5 and 83 mg/l for those living alone, with someone else, in a house of multiple occupancy and in a nursing/residential home, respectively. Compared to living alone, living with anyone was associated with increased mortality: within a couple [adjusted hazard ratios (aHR) = 1.39, 95% confidence intervals (CI) 1.09-1.77, P = 0.007]; living in a house of multiple occupancy (aHR = 1.67, 95% CI 1.17-2.38, P = 0.005); and living in a residential home (aHR = 1.36, 95% CI 1.03-1.80, P = 0.031). For patients hospitalized with COVID-19, those living with one or more people had an increased association with mortality, they also exhibited higher CRP indicating increased disease severity suggesting they delayed seeking care.
Sections du résumé
BACKGROUND
In response to the COVID-19 pandemic, many countries mandated staying at home to reduce transmission. This study examined the association between living arrangements (house occupancy numbers) and outcomes in COVID-19.
METHODS
Study population was drawn from the COPE study, a multicentre cohort study. House occupancy was defined as: living alone; living with one other person; living with multiple other people; or living in a nursing/residential home. Outcomes were time from admission to mortality and discharge (Cox regression), and Day 28 mortality (logistic regression) analyses were adjusted for key comorbidities and covariates including admission: age, sex, smoking, heart failure, admission C-reactive protein (CRP), chronic obstructive pulmonary disease, estimated glomerular filtration rate, frailty and others.
RESULTS
A total of 1584 patients were included from 13 hospitals across UK and Italy: 676 (42.7%) were female, 907 (57.3%) were male, median age was 74 years (range: 19-101). At 28 days, 502 (31.7%) had died. Median admission CRP was 67, 82, 79.5 and 83 mg/l for those living alone, with someone else, in a house of multiple occupancy and in a nursing/residential home, respectively. Compared to living alone, living with anyone was associated with increased mortality: within a couple [adjusted hazard ratios (aHR) = 1.39, 95% confidence intervals (CI) 1.09-1.77, P = 0.007]; living in a house of multiple occupancy (aHR = 1.67, 95% CI 1.17-2.38, P = 0.005); and living in a residential home (aHR = 1.36, 95% CI 1.03-1.80, P = 0.031).
CONCLUSION
For patients hospitalized with COVID-19, those living with one or more people had an increased association with mortality, they also exhibited higher CRP indicating increased disease severity suggesting they delayed seeking care.
Identifiants
pubmed: 33999142
pii: 6276987
doi: 10.1093/eurpub/ckab085
pmc: PMC8247274
doi:
Types de publication
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
133-139Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.
Références
Nat Hum Behav. 2020 May;4(5):460-471
pubmed: 32355299
Lancet Respir Med. 2020 Sep;8(9):e70
pubmed: 32771081
Lancet. 2007 Oct 20;370(9596):1453-7
pubmed: 18064739
Psychol Sci. 2006 May;17(5):407-13
pubmed: 16683928
Lancet Public Health. 2020 Aug;5(8):e444-e451
pubmed: 32619408
Int J Cardiol Heart Vasc. 2020 Dec;31:100660
pubmed: 33083516
J Clin Med. 2020 Aug 10;9(8):
pubmed: 32785086
J Hosp Infect. 2020 Oct;106(2):376-384
pubmed: 32702463
Lancet. 2020 Jun 27;395(10242):1973-1987
pubmed: 32497510
J Clin Nurs. 2020 Aug;29(15-16):2760-2761
pubmed: 32406958
BMJ Open. 2020 Sep 29;10(9):e040569
pubmed: 32994260
Int J Epidemiol. 2021 May 17;50(2):420-429
pubmed: 33683344
JAMA. 2020 Jul 7;324(1):23-24
pubmed: 32442303